Hypertension
Aires Pharmaceuticals Signs Key Technology License Agreement With the National Institutes of Health
Published in Medical Letter on the CDC and FDA, November 9th, 2008
The technology, identified at the NIH's National Heart, Blood and Lung Institute, shows that nitrite, which is converted by the body into nitric oxide, can be delivered as an effective treatment for pulmonary hypertension, myocardial infarction, transplantation and cerebral vasospasm. Aires Pharmaceuticals is developing Aironite(TM), a proprietary, inhalable formulation of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Alzheimer Disease
'Poetry From the Heart By an Alzheimer's Caregiver': Touching New Poetry Collection Explores Devastating Emotional Experience - Behavior
Research from Chonnam National University in the area of behavior published - Cancer
New research on cancer from University of California summarized - Elan Corporation, plc and Transition Therapeutics
Elan and Transition Therapeutics Achieve Patient Enrollment Target in Phase 2 Clinical Study of ELND005 AZD-103 in Alzheimer's Disease - Escherichia Coli
E. coli O157 Vaccine Efficacy Reinforced by Study Published in Foodborne Pathogens and Disease - Life Sciences
Data on life sciences reported by S. Ekins and co-researchers - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
